Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients

Class of 2012 Abstract === Specific Aims: During pre-hospital transport, trauma patients may be given a long-acting neuromuscular blocker (NMB) to facilitate endotracheal intubation or to prevent movement. The purpose of this study was to determine the rate of long-acting NMB use and evaluate the co...

Full description

Bibliographic Details
Main Authors: Elofson, Kathryn, Girardot, Sarah
Other Authors: Patanwala, Asad
Language:en_US
Published: The University of Arizona. 2012
Subjects:
Online Access:http://hdl.handle.net/10150/623607
http://arizona.openrepository.com/arizona/handle/10150/623607
id ndltd-arizona.edu-oai-arizona.openrepository.com-10150-623607
record_format oai_dc
spelling ndltd-arizona.edu-oai-arizona.openrepository.com-10150-6236072017-05-25T03:00:59Z Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients Elofson, Kathryn Girardot, Sarah Patanwala, Asad College of Pharmacy, The University of Arizona neuromuscular blocker (NMB) Traumatic Injury Intubation Class of 2012 Abstract Specific Aims: During pre-hospital transport, trauma patients may be given a long-acting neuromuscular blocker (NMB) to facilitate endotracheal intubation or to prevent movement. The purpose of this study was to determine the rate of long-acting NMB use and evaluate the concurrent use of sedatives. Methods: This was a retrospective cohort study conducted in a tertiary care, academic emergency department of trauma patients aged 18-89 years who were intubated in the pre-hospital setting. The primary outcome was to determine the rate of long-acting NMB use. The use of post- intubation sedatives was compared between the groups using Wilcoxon rank-sum test or Fisher’s exact test, using an a priori alpha level of 0.05 for all analyses. Main Result: A total of 51 patients were included in final analyses. All patients received etomidate or midazolam for intubation. 86% (n=44) received succinylcholine, 10% (n=5) were given rocuronium and 4% (n=2) did not receive a NMB. After intubation, 75% (n=38) received an additional long-acting NMB to prevent movement (vecuronium (n=22) or rocuronium (n=16)) . Overall, 82% (n=42) of patients received a long- acting NMB during transport. There was no difference in the rate of post-intubation sedative use between groups (79% versus 67%, respectively, p=0.42). The long-acting NMB group received midazolam less promptly after intubation (16 versus 7 minutes, respectively, p=0.04). Conclusions: The use of long-acting NMB is common during the pre-hospital transport of trauma patients. Some of these patients may not be given sedatives or have delays in receiving sedatives following intubation and be at risk of being paralyzed without sedation. 2012 text Electronic Report http://hdl.handle.net/10150/623607 http://arizona.openrepository.com/arizona/handle/10150/623607 en_US Copyright © is held by the author. The University of Arizona.
collection NDLTD
language en_US
sources NDLTD
topic neuromuscular blocker (NMB)
Traumatic Injury
Intubation
spellingShingle neuromuscular blocker (NMB)
Traumatic Injury
Intubation
Elofson, Kathryn
Girardot, Sarah
Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
description Class of 2012 Abstract === Specific Aims: During pre-hospital transport, trauma patients may be given a long-acting neuromuscular blocker (NMB) to facilitate endotracheal intubation or to prevent movement. The purpose of this study was to determine the rate of long-acting NMB use and evaluate the concurrent use of sedatives. Methods: This was a retrospective cohort study conducted in a tertiary care, academic emergency department of trauma patients aged 18-89 years who were intubated in the pre-hospital setting. The primary outcome was to determine the rate of long-acting NMB use. The use of post- intubation sedatives was compared between the groups using Wilcoxon rank-sum test or Fisher’s exact test, using an a priori alpha level of 0.05 for all analyses. Main Result: A total of 51 patients were included in final analyses. All patients received etomidate or midazolam for intubation. 86% (n=44) received succinylcholine, 10% (n=5) were given rocuronium and 4% (n=2) did not receive a NMB. After intubation, 75% (n=38) received an additional long-acting NMB to prevent movement (vecuronium (n=22) or rocuronium (n=16)) . Overall, 82% (n=42) of patients received a long- acting NMB during transport. There was no difference in the rate of post-intubation sedative use between groups (79% versus 67%, respectively, p=0.42). The long-acting NMB group received midazolam less promptly after intubation (16 versus 7 minutes, respectively, p=0.04). Conclusions: The use of long-acting NMB is common during the pre-hospital transport of trauma patients. Some of these patients may not be given sedatives or have delays in receiving sedatives following intubation and be at risk of being paralyzed without sedation.
author2 Patanwala, Asad
author_facet Patanwala, Asad
Elofson, Kathryn
Girardot, Sarah
author Elofson, Kathryn
Girardot, Sarah
author_sort Elofson, Kathryn
title Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
title_short Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
title_full Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
title_fullStr Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
title_full_unstemmed Long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
title_sort long-acting neuromuscular blocker use during pre-hospital transport of critically ill trauma patients
publisher The University of Arizona.
publishDate 2012
url http://hdl.handle.net/10150/623607
http://arizona.openrepository.com/arizona/handle/10150/623607
work_keys_str_mv AT elofsonkathryn longactingneuromuscularblockeruseduringprehospitaltransportofcriticallyilltraumapatients
AT girardotsarah longactingneuromuscularblockeruseduringprehospitaltransportofcriticallyilltraumapatients
_version_ 1718453562150748160